|
CCCC C4 Therapeutics, Inc 1662579 |
| Balance Sheet |
|
Current Assets
|
$262,902,000.00 |
|
Assets
|
$359,404,000.00 |
|
Current Liabilities
|
$48,247,000.00 |
|
Liabilities
|
$112,139,000.00 |
|
Equity
|
$247,265,000.00 |
|
Shares Out
|
122905756.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-31,518,000.00 |
|
Investing Cash Flow
|
$1,338,000.00 |
| Market Analysis |
Market Cap
|
$495,310,196.68 |
|
Price
|
$4.03 |
|
BVPS
|
2.01 |
|
PB
|
2.01 |
|
EPS
|
-0.18 |
|
PS
|
18.65 |
|
FCF
|
$-31,619,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:40 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:31 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.18 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-12 |
-0.20 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.37 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.44 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CCCC documents filed with the SEC.
CCCC Filings
Clear
